Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Antibiotic Treatment to Patients With Low Back Pain

This study has been completed.
Information provided by:
The Back Research Center, Denmark Identifier:
First received: March 14, 2006
Last updated: May 26, 2010
Last verified: July 2009

A large proportion of patients with Low Back Pain (LBP) (80 %) are classified as "non-specific", due to the lack of a patho-anatomical diagnosis. This term is not satisfactory, since it implies uncertainty for both the patient and the clinician. Modic changes have recently been identified as a pain giving patho-anatomical diagnosis for a considerable percentage (20-30 %) of LBP patients. The causes of these Modic changes have not been determined conclusively but bacterial infection is among the plausible causes for those following a disc herniation.

Purpose The aim of this study is to assess the clinical effect of antibiotic treatment compared to placebo, in patients with LBP and Modic changes following a lumbar herniated disc.

Design A double blind prospective clinically controlled trial. Patients will be randomized by a blinded observer to either Group A: 1 antibiotic tablet 45 patients Group B: 1 placebo tablet 36 patients Group C: 2 antibiotic tablets 45 patients Group D: 2 placebo tablets 36 patients

The patients will take the drug three times a day for 100 days.

Condition Intervention Phase
Back Pain
Drug: Bioclavid
Drug: Placebo
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Antibiotic Treatment to Patients With Low Back Pain Associated With Modic Changes Following Disc Herniation. A Randomized Clinical Controlled Trial

Resource links provided by NLM:

Further study details as provided by The Back Research Center, Denmark:

Primary Outcome Measures:
  • Low Back Pain Roland Morris Questionaire [ Time Frame: One year follow-up ]

Enrollment: 162
Study Start Date: March 2006
Study Completion Date: October 2009
Primary Completion Date: October 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Group A, Antibiotic
1 antibiotic tablet 45 patients Group
Drug: Bioclavid
500 + 125 mg times 3 or 6
Placebo Comparator: Group B: 1 placebo
1 placebo tablet
Drug: Placebo
Experimental: Group C: Antibiotics
2 antibiotic tablets 45 patients
Drug: Bioclavid
500 + 125 mg times 3 or 6
Placebo Comparator: Group D, Placebo
2 placebo tablets 36 patients
Drug: Placebo


Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Age between 18-65 years
  • Previous lumbar herniated disc confirmed by MRI
  • Time since lumbar disc herniation more than 6 months less than 2 years
  • LBP in the area of L1 to L5, with an added Low Back Pain Rating Scale of 6 or more
  • The present MRI shows Modic changes
  • Positive Springing test (SPT) at the level of Modic changes

Exclusion Criteria:

  • Allergy against antibiotics
  • The Beck Depression Inventory >7,
  • Pregnancy
  • Breast feeding
  • All Kidney diseases
  • Pending workers litigation or pension
  • Danish as second language
  • Fertile women who do not user safe anti conseption
  • Reduced liver functions
  • Reduced liver function due to previous treatment wiht amoxicillin/clavulanasid.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00302796

The Back Research Center
Ringe, Denmark, 5230
Sponsors and Collaborators
The Back Research Center, Denmark
Principal Investigator: Hanne B Albert, Ph.D The Back Research Center, University of Southern Denmark
  More Information

Responsible Party: Hanne Albert, The Back Research Center Identifier: NCT00302796     History of Changes
Other Study ID Numbers: 2005-005500-17
Study First Received: March 14, 2006
Last Updated: May 26, 2010

Keywords provided by The Back Research Center, Denmark:
Low Back Pain,

Additional relevant MeSH terms:
Back Pain
Low Back Pain
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms
Anti-Bacterial Agents
Antibiotics, Antitubercular
Anti-Infective Agents
Antitubercular Agents processed this record on May 25, 2017